In NSCLC, it inhibited cell proliferation and infiltration by directly targeting SOX9, PTPN1, and USP22-mediated Sirt1/JAK/STAT3 signaling [8, 35, 36]. This evidence concerns the gene SIRT1 and non-small cell lung carcinoma.